Texas A&M Unveils PertReason AI Virtual Cell Model

The model predicts how genetic and drug effects alter cellular behavior and is slated for presentation at NeurIPS 2026.

Updated on Nov. 20, 2026 in Life Sciences

Flat-color editorial illustration of a clear glass cell-culture flask with amber filaments branching outward, evoking AI-traced biological pathways.
Texas A&M researchers unveiled PertReason, an AI virtual cell model that predicts how genetic changes and drugs alter cell behavior, ahead of its NeurIPS 2026 presentation. AI Illustration. Upload story photo >

Texas A&M University researchers have developed PertReason, an AI virtual cell model that predicts how genetic changes and drugs alter cellular behavior. The paper was accepted for presentation at the Conference on Neural Information Processing Systems (NeurIPS 2026).

Why it matters

Current AI models can predict whether someone with a genetic change will develop a disease but cannot explain why it occurred or how to design a treatment. PertReason aims to fill that gap by tracing the biological pathways behind cellular changes, which could help scientists focus on the most promising leads for College Station and beyond.

The PertReasonQA benchmark identifies cases where a model produced a correct answer without using the proper data, a flaw the team designed the test to catch. Performance comparisons against competing models were not included in the available information.

The players

Texas A&M University

A public research university in College Station, Texas, known for its engineering and life sciences programs.

Conference on Neural Information Processing Systems (NeurIPS)

One of the most prestigious annual conferences in machine learning and computational neuroscience.

The details

The team applies electrical engineering principles to trace the processes behind cellular changes and trained an AI model to reason through biological pathways. An earlier version was presented in July at the 3rd Workshop on Multi-modal Foundation Models and Large Language Models for Life Sciences during ICML 2026 in Seoul, South Korea, and the paper is available on the arXiv preprint server.

Timeline

  1. July 2026: An earlier version of PertReason was presented at an ICML 2026 workshop in Seoul, South Korea.

  2. 2026: PertReason was accepted for presentation at NeurIPS 2026.

The Big Picture

PertReason extends the virtual cell modeling effort in computational biology by moving beyond outcome prediction toward explaining the biological pathways behind cellular changes. The work signals a shift in the field toward models that can justify their reasoning, not just their outputs.

If PertReason's reasoning approach proves reliable, it could eventually help researchers narrow the list of drug and genetic targets to test in the lab. Any practical benefit to patients would depend on follow-up validation beyond the conference presentation.

The takeaway

AI models that can explain biological reasoning, not just predict outcomes, may help scientists choose better experiments. Readers should watch for independent validation of PertReason's results as the NeurIPS 2026 presentation approaches.

Further reading

For more on related research, explore the Life Sciences coverage on Wisevoter.

Source note: This article includes information reported by Phys.